Catalyst Pharmaceuticals, Inc. (CPRX)
31.33
+0.07
(+0.22%)
USD |
NASDAQ |
May 26, 16:00
31.32
-0.01
(-0.03%)
After-Hours: 18:34
Catalyst Pharmaceuticals Shareholders Equity (Quarterly) : 1.013B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 390.32M |
| Inovio Pharmaceuticals, Inc. | 6.068M |
| United Therapeutics Corp. | 5.901B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Agios Pharmaceuticals, Inc. | 1.109B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.148B |
| Total Liabilities (Quarterly) | 134.91M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |